185 related articles for article (PubMed ID: 1339115)
1. Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Eperimental toxicity and pharmacokinetics, and clinical trial.
Díaz-Llopis M; Martos MJ; España E; Cervera M; Vila AO; Navea A; Molina FJ; Romero FJ
Doc Ophthalmol; 1992; 82(4):297-305. PubMed ID: 1339115
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal ganciclovir pharmacokinetics in rabbits and man.
Ashton P; Brown JD; Pearson PA; Blandford DL; Smith TJ; Anand R; Nightingale SD; Sanborn GE
J Ocul Pharmacol; 1992; 8(4):343-7. PubMed ID: 1336537
[TBL] [Abstract][Full Text] [Related]
5. Pathology of cytomegalovirus retinitis treated with sustained release intravitreal ganciclovir.
Anand R; Font RL; Fish RH; Nightingale SD
Ophthalmology; 1993 Jul; 100(7):1032-9. PubMed ID: 8391675
[TBL] [Abstract][Full Text] [Related]
6. Release kinetics of liposome-encapsulated ganciclovir after intravitreal injection in rabbits.
Le Bourlais C; Chevanne F; Ropert P; Bretagne G; Acar L; Zia H; Sado PA; Needham T; Leverge R
J Microencapsul; 1996; 13(4):473-80. PubMed ID: 8808783
[TBL] [Abstract][Full Text] [Related]
7. Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device.
Sanborn GE; Anand R; Torti RE; Nightingale SD; Cal SX; Yates B; Ashton P; Smith T
Arch Ophthalmol; 1992 Feb; 110(2):188-95. PubMed ID: 1310587
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS.
Akula SK; Ma PE; Peyman GA; Rahimy MH; Hyslop NE; Janney A; Ashton P
Br J Ophthalmol; 1994 Sep; 78(9):677-80. PubMed ID: 7947546
[TBL] [Abstract][Full Text] [Related]
9. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Toyoguchi M; Bergeron-Lynn G; Freeman WR
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):515-21. PubMed ID: 11818399
[TBL] [Abstract][Full Text] [Related]
10. [Treatment with intravitreous ganciclovir in cytomegalovirus retinitis associated with AIDS].
Gutiérrez A; Martín I; Ferrer E; Torrón C; Aguirre JM
Enferm Infecc Microbiol Clin; 1992 Dec; 10(10):629-30. PubMed ID: 1337981
[No Abstract] [Full Text] [Related]
11. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.
Flores-Aguilar M; Kuppermann BD; Quiceno JI; Dankner WM; Wolf DG; Capparelli EV; Connor JD; Sherwood CH; Fullerton S; Gambertoglio JG
Ophthalmology; 1993 Jul; 100(7):1022-31. PubMed ID: 8391674
[TBL] [Abstract][Full Text] [Related]
13. A modified procedure for intravitreal injections of ganciclovir in the treatment of cytomegalovirus retinitis.
Baudouin C; Gastaud P
Ophthalmology; 1992 Aug; 99(8):1183. PubMed ID: 1325043
[No Abstract] [Full Text] [Related]
14. High dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitis.
Young SH; Morlet N; Heery S; Hollows FC; Coroneo MT
Med J Aust; 1992 Sep; 157(6):370-3. PubMed ID: 1333036
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome.
Cochereau-Massin I; Lehoang P; Lautier-Frau M; Zazoun L; Marcel P; Robinet M; Matheron S; Katlama C; Gharakhanian S; Rozenbaum W
Ophthalmology; 1991 Sep; 98(9):1348-53; discussion 1353-5. PubMed ID: 1658703
[TBL] [Abstract][Full Text] [Related]
16. [Intravitreal injection of ganciclovir in AIDS patients with cytomegalovirus retinitis].
Fujino Y; Nagata Y; Miyoshi M; Ono A; Oka S; Iwamoto A; Kimura S; Mochizuki M
Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):634-40. PubMed ID: 8810241
[TBL] [Abstract][Full Text] [Related]
17. Technique of intravitreal injection.
Morlet N; Young S; Strachan D; Coroneo MT
Aust N Z J Ophthalmol; 1993 May; 21(2):130-1. PubMed ID: 8392851
[No Abstract] [Full Text] [Related]
18. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
Ausayakhun S; Yuvaves P; Ngamtiphakom S; Prasitsilp J
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S15-20. PubMed ID: 16681046
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy.
Kuppermann BD; Quiceno JI; Flores-Aguilar M; Connor JD; Capparelli EV; Sherwood CH; Freeman WR
J Infect Dis; 1993 Dec; 168(6):1506-9. PubMed ID: 8245536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
